Literature DB >> 4055488

Effect of atrophic rhinitis on growth rate in Illinois swine herds.

L Bäckström, D C Hoefling, A C Morkoc, R P Cowart.   

Abstract

Influence of atrophic rhinitis (AR) on mean daily weight gain (MDG) was studied in hogs randomly selected from 7 farrow-to-finish herds in Illinois. Herds were selected to obtain a wide range of clinical signs and lesions of the disease; thus, prevalence of clinical signs of AR in finishing hogs ranged from 0% to 20% among herds, and in hogs examined at slaughter the proportion of hogs with turbinate lesions ranged from 5% to 92%. None of the herds investigated had any obvious problems with pneumonia; nevertheless, hogs with moderate to severe pneumonic lesions were excluded from the study, to minimize any combined effect of AR and pneumonia. In 3 herds, MDG in AR-free pigs was 15% to 18% better than in pigs with severe AR lesions. Prevalence of clinical signs ranged from 5% to 20%, and of turbinate lesions, from 66% to 92%. In 4 herds in which MDG appeared to be unaffected by AR, prevalence of clinical signs of the disease ranged from 0% to 5%, and of turbinate lesions, from 5% to 74%. No consistent pattern of influence on AR lesions was found for bacterial infections, as determined by culturing of nasal swab specimens on MacConkey agar and blood agar.

Entities:  

Mesh:

Year:  1985        PMID: 4055488

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  10 in total

1.  Distribution of atrophy in the nasal ventral conchae of piglets infected experimentally with Bordetella bronchiseptica.

Authors:  B Martineau-Doizé; H Trépanier; G P Martineau
Journal:  Can J Vet Res       Date:  1991-07       Impact factor: 1.310

2.  The effect of atrophic rhinitis on growth rate.

Authors:  K J Baalsrud
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

3.  Vaccination against atrophic rhinitis: effect on clinical symptoms, growth rate and turbinate atrophy.

Authors:  K J Baalsrud
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

4.  Development of turbinate lesions and nasal colonization by Bordetella bronchiseptica and Pasteurella multocida during long-term exposure of healthy pigs to pigs affected by atrophic rhinitis.

Authors:  L R Bäckström; T A Brim; M T Collins
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

5.  Direct PCR analysis for toxigenic Pasteurella multocida.

Authors:  C A Lichtensteiger; S M Steenbergen; R M Lee; D D Polson; E R Vimr
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Atrophic rhinitis caused by Pasteurella multocida type D: morphometric analysis.

Authors:  B Martineau-Doizé; G Dumas; R Larochelle; J C Frantz; G P Martineau
Journal:  Can J Vet Res       Date:  1991-07       Impact factor: 1.310

7.  Epidemiological associations between Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae antibody titers and lung lesions in Prince Edward Island swine herds.

Authors:  L D Van Til; I R Dohoo; R S Morley
Journal:  Can J Vet Res       Date:  1991-10       Impact factor: 1.310

8.  Pasteurella multocida and Bordetella bronchiseptica in atrophic rhinitis and pneumonia in swine.

Authors:  R P Cowart; L Bäckström; T A Brim
Journal:  Can J Vet Res       Date:  1989-07       Impact factor: 1.310

9.  An epidemiologic and economic study of respiratory diseases in two conventional Danish swine herds. II: Associations between lesions present at slaughter and mean daily gains during specific intervals of the growth period.

Authors:  L G Paisley; L Vraa-Andersen; L Dybkjaer; K Møller; G Christensen; J Mousing; J F Agger
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

10.  An epidemiologic and economic study of respiratory diseases in two conventional Danish swine herds. I: Prevalence of respiratory lesions at slaughter and their effects on growth.

Authors:  L G Paisley; L Vraa-Andersen; L Dybkjaer; K Møller; G Christensen; J Mousing; J F Agger
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.